Skip to content
NCBNational Capability Benchmark
Navigate with ↑ ↓Enter to openEsc to close

Challenge the benchmark

Choose a score and give the benchmark a specific reason to reconsider it.

The selected score and confidence are read from the current country file when you submit.

Submissions are public and start as awaiting review. A maintainer can add a response and signature after review.

What countries built

Each record describes something a country built that the indicators miss. The source provides the number; the mechanism is our interpretation.

Scores describe outcomes. These records describe how a country acted, what it needed and what happened. 204 of 204 records include a mechanism. They do not affect scores.

Narrow the list

9 of 204 deliveries

Experimentation

9 deliveries linked to Regulatory sandbox activity, Venture capital investment, Business share of R&D, University spinouts.

United Kingdomsince 2016still operatingbears on Regulatory sandbox activity

The FCA regulatory sandbox

The United Kingdom's financial regulator built the first regulatory sandbox in 2016, and by the end of 2022 had accepted 168 firms and products to test with real customers under supervision.

168 firms, firms and products accepted for testing since launch, 2022. Financial Conduct Authority, Innovation Hub market insights, retrieved 2026-08-27.

The move, and what it needed

The regulator wrote a bounded testing regime: a firm without full authorisation can trial a product on real customers for a fixed period, with disclosure requirements and an exit plan, while the regulator watches from inside.

Preconditions

  • A single conduct regulator with statutory room to waive its own rules
  • A fintech sector dense enough to fill cohorts
  • Political cover for a regulator explicitly helping firms it will later police

Where it travelled: The sandbox is Britain's most copied regulatory export, and several dozen jurisdictions now run one. Most copies keep the name and drop the supervisory intensity that makes it work.

Limits: The count is the regulator reporting on its own programme, and acceptance is not success: the FCA does not publish how many tests led to authorisation, funding or a product that survived. One hundred and sixty-eight firms over seven years is small next to the sector, so the number evidences that the mechanism runs, not that it moves the industry.

Israelsince 1993delivered and closedbears on Venture capital investment

Yozma, the venture capital catalyst

Israel put 100 million dollars of public money into ten hybrid venture funds from 1993, with foreign partners and a buy-out option, and by 2002 the country had 131 venture funds with around 10 billion dollars under management.

10,000,000,000 US dollars, capital under management by israeli venture funds, 2002. 100,000,000 US dollars, government capital that started yozma, 1993. OECD, Venture Capital Policies in Israel, STI working paper 2003/3, retrieved 2026-08-27.

The move, and what it needed

The state capitalised new private funds rather than picking companies, required each fund to bring a foreign venture firm as partner, and sold the government's stake cheaply to the private partners once a fund worked, so the subsidy was the upside, and it expired by design.

Preconditions

  • A stock of investable technology and founders already present
  • Foreign venture firms willing to teach the craft for cheap equity
  • A government able to exit a working programme instead of scaling it

Where it travelled: Yozma is the most copied venture policy in the world, and most copies fail on the same two points: no credible foreign-partner requirement, and no willingness to sell the state's stake at the moment of success.

Limits: Attribution is the weak joint: the ten funds were one cause among several, alongside a million-person skilled immigration wave, military technology spillovers and a US stock market that wanted Israeli listings, and the OECD paper credits Yozma as catalyst rather than cause. The 10 billion figure is capital under management, not investment made or returns earned, and roughly 70 percent of it was foreign money. The programme was deliberately closed once private capital led, which is why the status is concluded.

Brazilsince 2013still operatingbears on Business share of R&D

EMBRAPII, industry-led applied research

Created in 2013, EMBRAPII connects companies to public and private research units through shared-risk funding, and it contracted a record 811 new industrial research projects in 2025.

811 projects, new projects contracted in the year, 2025. EMBRAPII, 2025 results, retrieved 2026-08-29.

The move, and what it needed

Public funding follows an industry's defined technical problem into a research unit, sharing early risk while leaving the company and researchers responsible for solving a concrete challenge.

Preconditions

  • Research units with equipment and technical depth ready to work with firms
  • Companies able to define a problem and contribute a financial counterpart
  • A funding body with enough flexibility to contract applied work faster than ordinary grants

Limits: Project counts show the throughput of a funding network, not the commercial value, technical success or additionality of the research. EMBRAPII's own results report the programme's activity, and projects vary widely in scale and maturity.

South Koreasince 2019still operatingbears on Regulatory sandbox activity

Korean regulatory-sandbox system across eight sectors

South Korea expanded its regulatory-sandbox system from ICT and industrial-convergence fields in January 2019 to eight sectoral regimes by 2024, adding finance, regulatory-free zones, smart cities, R&D zones, mobility and circular economy testing.

8 regimes, sectoral regulatory-sandbox regimes operating, 2024-01. Government of the Republic of Korea, Regulatory Sandbox portal, retrieved 2026-08-31.

The move, and what it needed

South Korea created a common regulatory-sandbox architecture with temporary permits, demonstration exemptions and rapid regulatory confirmation, then added sector-specific tracks and dedicated support bodies so smaller firms could test products without negotiating every rule from scratch.

Preconditions

  • A legal framework that allows time-, place- and scale-limited exemptions while retaining safety controls
  • Specialist ministries and intake bodies able to assess experiments across finance, mobility, ICT and industrial sectors
  • A route from a successful test to regulatory revision, licensing or procurement rather than leaving pilots stranded

Where it travelled: Sandbox systems travel when experimentation, safeguards and rule-change pathways are designed together; multiplying sector labels without review capacity creates a catalogue rather than a learning system.

Limits: The regime count shows institutional breadth, not the number of firms approved, experiments completed, commercial products launched, safety outcomes or permanent rule changes. The government portal describes the system's design and expansion but does not independently evaluate whether each sectoral track is active at the same intensity or produces net social benefit.

Singaporesince 2016still operatingbears on Regulatory sandbox activity

MAS FinTech Regulatory Sandbox variants

Singapore's Monetary Authority operates three FinTech Regulatory Sandbox variants—Sandbox, Sandbox Express and Sandbox Plus—giving firms distinct routes to test regulated products with real customers under defined safeguards.

3 sandbox variants, mas fintech regulatory sandbox variants, 2022. Singapore Economic Development Board, overview of the MAS FinTech Regulatory Sandbox, retrieved 2026-08-31.

The move, and what it needed

MAS made experimentation a staged regulatory service: firms needing tailored controls use the original sandbox, lower-risk activities can use Sandbox Express, and promising proposals can receive a streamlined route with support. Each variant keeps a live test bounded while giving the regulator evidence before a full licence.

Preconditions

  • A financial regulator with authority to vary requirements temporarily and monitor live customer activity
  • Clear entry, boundary and exit criteria so a sandbox does not become indefinite unlicensed operation
  • A dense financial and technology ecosystem in which tested products can find counterparties, capital and a path to licensing

Where it travelled: Regulatory sandboxes travel best as a portfolio matched to risk: one universal process can be too slow for low-risk tests and too loose for products that move real money.

Limits: Counting three sandbox routes shows regulatory design and breadth, not applications received, firms graduating to full licences, customer protection, failure rates or the cost of supervision. The EDB account is an official ecosystem description and includes illustrative company cases rather than an independent evaluation of all experiments.

United Kingdomsince 2018still operatingbears on Venture capital investment

British Patient Capital, a public venture-capital catalyst

The British Business Bank reported that government-owned British Patient Capital had committed £2.287 billion through 80 fund commitments, 10 co-investments and 18 Future Fund deals by 31 March 2024, with an underlying portfolio of 1,350 companies.

2,287,000,000 GBP, british patient capital commitments since inception, 2024-03-31. 1,350 companies, underlying portfolio companies, 2024-03-31. British Business Bank, British Patient Capital 2023–24 full-year results, retrieved 2026-08-31.

The move, and what it needed

The UK used a public, long-horizon investment platform to anchor private funds, make selected co-investments and keep capital flowing into innovative companies that can be underserved by shorter-horizon finance. A fund-manager network spreads sourcing and specialist judgement beyond the state balance sheet.

Preconditions

  • A public investment institution with a mandate, capital and governance that can tolerate long time horizons
  • Private fund managers and co-investors able to select, price and support high-growth firms
  • A pipeline of investable companies and follow-on capital so an anchor commitment can compound rather than stand alone

Where it travelled: Public venture catalysts travel when they crowd in capable private managers and preserve commercial decision-making; a state fund without deal flow, follow-on finance or disciplined governance can become a subsidy ledger rather than a capital market.

Limits: Commitments, assets and portfolio-company counts are administrative programme totals, not venture capital as a share of GDP, additionality, exits, jobs or causal economic impact. The portfolio includes third-party fund capital and co-investments, and the figures are reported by the government-owned delivery institution rather than independently evaluating what would have happened without it.

United Kingdomsince 2014still operatingbears on University spinouts

ICURe, from university research to spinouts

UK Research and Innovation's ICURe impact report says spinout companies from the programme secured £326 million in investment funding and created more than 1,400 jobs from 2014 onward, after research teams were trained and funded to test markets before deciding whether to spin out.

326,000,000 GBP, investment secured by icure spinouts, 2024. 1,400 jobs, jobs created by icure spinouts, 2024. UK Research and Innovation, ICURe impact report, retrieved 2026-08-31.

The move, and what it needed

ICURe gives research teams funding, coaching and a disciplined market-discovery period in which they conduct more than 100 customer interviews before a university-backed go/no-go decision. Teams advised to spin out can then apply for follow-on funding, turning technology-transfer work into an investable proposition rather than treating a patent as a company.

Preconditions

  • Universities and research institutes with discoveries, translational staff and authority to support commercial routes
  • Researchers willing to test a problem with users and founders able to lead a company after the discovery phase
  • Follow-on grants, investors and technology-transfer offices that can carry a validated opportunity beyond the programme

Where it travelled: Spinout pipelines travel when market discovery, founder formation and follow-on capital are designed as one chain; a grant or patent alone does not create the commercial capabilities and decisions needed for a durable firm.

Limits: The impact report's cumulative investment and job figures cover teams supported by ICURe and do not show the full spinout population, survival, profitability, quality of jobs, counterfactual or the programme's independent contribution. They are programme impact estimates, not a national spinout rate or a guarantee that every participating discovery should become a company.

United Kingdomsince 1981still operatingbears on Business share of R&D

Business-funded R&D as the UK's dominant research sector

The Office for National Statistics reported that UK businesses performed £50.0 billion of R&D in 2023, 69% of the country's £72.6 billion gross domestic R&D total.

69 % of R&D, business share of uk-performed r&d, 2023. 50,000,000,000 GBP, business-performed r&d expenditure, 2023. UK Office for National Statistics, Gross domestic expenditure on research and development: UK 2023, retrieved 2026-08-31.

The move, and what it needed

The UK combines a large private R&D base with public research funding and tax support, leaving firms as the main performers of national R&D while universities and government supply complementary research and talent. The sector mix gives commercial problems a route into the research system, but it also makes the national portfolio sensitive to corporate concentration and cycles.

Preconditions

  • Firms with the cash flow, engineering talent and appropriable returns needed to sustain R&D beyond a single grant
  • Universities and public laboratories that train researchers and can collaborate with or supply firms
  • Stable measurement, intellectual-property rules and public co-funding that make long-horizon private research investable

Where it travelled: A business-led R&D mix travels when private firms have reasons to keep investing and public institutions fill the basic-research and talent gaps; a high share alone can also reflect a few concentrated corporate laboratories.

Limits: The 69% share is a national R&D composition measure, not evidence that business research is basic, additional, productive or evenly distributed across firms and regions. ONS changed the business-survey methods for 2022, so the long historical series needs care; the figures measure R&D performed in UK organisations regardless of the ultimate owner's country.

Portugalsince 2012still operatingbears on Venture capital investment

Portugal Ventures, a public venture-capital bridge

Portugal Ventures, the public venture-capital company in the Banco Português de Fomento group, reports €233.2 million invested in 256 new companies since 2012 and €283 million under management.

233,200,000 EUR invested, invested since launch, 2026-08-31. 256 companies, new companies backed since launch, 2026-08-31. Portugal Ventures, institutional performance figures, retrieved 2026-08-31.

The move, and what it needed

A state-backed investor supplies pre-seed, seed and Series A capital, often alongside private investors, using staged minority investments and portfolio support to bridge companies that are too early for ordinary bank finance.

Preconditions

  • A pipeline of founders and research-derived firms large enough to fill investment rounds
  • Investment professionals with authority to make commercial decisions inside a public mandate
  • Follow-on private capital and exit markets so public money can recycle rather than become permanent subsidy

Where it travelled: Public venture capital travels when it crowds in follow-on investors and accepts portfolio risk transparently; a state fund that only replaces missing private money can preserve firms without building a market.

Limits: These are company-reported cumulative portfolio figures, not venture-capital investment as a share of GDP, additionality, exits, survival, jobs or a counterfactual. The homepage does not give a full reference-year methodology, and the totals can include private co-investment effects as well as Portugal Ventures' own capital.